哮喘药物市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00021879
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 191
Buy Now

哮喘药物市场预计将从 2021 年的 242.3917 亿美元增至 2028 年的 341.361 亿美元;预计 2021 年至 2028 年复合年增长率为 5.0%。

哮喘是一种肺部疾病,影响所有年龄段的人。它会产生喘息并使呼吸困难。接触过敏或刺激物、感染、锻炼、情绪压力和其他条件都是潜在的触发因素。当哮喘症状变得难以忍受时,哮喘就会发作。攻击可能会突然发生,范围从轻微到危及生命。哮喘可通过救援吸入器来治疗症状,并通过控制吸入器来预防症状。严重病例可能需要长效吸入器以保持呼吸道通畅(福莫特罗、沙美特罗、噻托溴铵)和吸入类固醇。哮喘药物有多种形式,包括片剂、注射剂、液体和吸入剂,分为支气管扩张剂和抗炎药两类。

哮喘药物市场根据药物进行细分、给药途径、分销渠道和地理位置。该市场根据地理位置大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。哮喘药物市场报告提供了对市场的见解和深入分析,强调市场规模、趋势和动态等参数;市场的技术进步;以及哮喘药物市场主要市场参与者的竞争格局分析。

战略见解

一些因素,例如日益增长的环境影响和哮喘药物市场的竞争格局。空气污染的遗传影响、特定种族群体的脆弱性、粗颗粒物暴露的增加、哮喘相关生理疾病的患病率不断上升,预计将对哮喘药物市场产生重大的短期、中期和长期影响。未来几年。然而,未满足的医疗需求和缺乏治疗依从性阻碍了市场的增长。市场报告确定了可能对市场增长产生影响的机会和未来市场趋势。

哮喘药物市场的利润丰厚的区域


市场洞察
日益增长的环境影响和环境影响空气污染的遗传影响

哮喘是一种慢性呼吸道疾病,其特征是气流受限波动、支气管高反应性和气道炎症。根据题为“空气污染对哮喘结果的影响”的评论论文, Tiotiu 等人指出,空气污染阻碍了成人和儿童的哮喘结局。交通造成的空气污染、二氧化氮 (NO2) 和二手烟 (SHS) 都是儿童患哮喘的重要危险因素。接触外部污染可能会引发哮喘症状、病情加重和肺功能下降。

在美国,接触空气污染仍然与哮喘有关。这种严重且危及生命的慢性呼吸道疾病影响着超过 2300 万美国公民的生活质量。空气污染会加重哮喘症状,引发哮喘发作。患有哮喘的儿童特别容易受到污染的影响,美国约有 600 万儿童患有哮喘。

美国环境保护署 (EPA) 资助的一项新研究分析了空气污染与哮喘之间的联系。虽然由于空气污染,专家无法确定导致哮喘的主要因素,但有证据表明,空气污染会抑制控制免疫系统区分过敏原和有害异物(例如病毒或细菌)的基因。然后,免疫系统就会过度运转,无论药物是否有毒,都会引发炎症反应,从而导致哮喘。

斯坦福大学儿童中心的研究人员调查了空气污染对涉及免疫耐受的两个基因的影响来自污染严重地区的儿童。他们发现,短期和长期接触大量一氧化碳 (CO)、NO2 和 PM2.5(颗粒物)与这些物质的变化有关。导致哮喘的两个基因。这些发现重点关注空气污染暴露对表观遗传的影响,可能有助于开发预防性哮喘药物。

每项哮喘研究都增进了对儿童哮喘的了解,并向 EPA 提供了重要信息:可用于保护人类健康和环境。通过这些研究工作,哮喘药物的发现和开发正在加速,从而推动哮喘药物市场的发展。

基于药物类型的见解

全球哮喘药物市场,基于药物治疗分为快速缓解药物和长期控制药物。预计长期控制药物领域将在未来几年占据更大的市场份额。然而,快速缓解药物领域预计在预测期内将出现更高的复合年增长率。

哮喘药物市场,按药物分类 - 2021年和2028年

基于给药途径的见解

根据给药途径,哮喘药物市场分为吸入型、预充注射器/小瓶、和别的。吸入型细分市场在 2021 年占据最大市场份额,预计在预测期内将占据重要份额。然而,预计 2021 年至 2028 年预充式注射器/小瓶细分市场的复合年增长率最高。

基于分销渠道的见解

根据分销渠道,哮喘药物市场被细分分为网上药房、医院药房和零售药房。预计零售药房领域在预测期内将占据最大的市场份额。然而,在线药店领域预计在 2021 年至 2028 年期间复合年增长率最高。

在哮喘药物市场运营的各种公司采取产品发布、并购、合作、产品创新等策略,产品组合扩展,以扩大其在全球的足迹,维护品牌名称并满足不断增长的消费者需求。市场上的一些领先企业包括阿斯利康 (AstraZeneca);梯瓦制药工业有限公司;葛兰素史克公司;勃林格殷格翰国际有限公司;默克公司有限公司;皇家飞利浦公司;赛诺菲;辉瑞公司;诺华公司;和雅培。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the asthma drugs?

Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.

What are the driving factors for the asthma drugs market across the globe?

The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.

What are the restraining factors for the asthma drugs market across the globe?

The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.

Who are the major players in the market the asthma drugs market?

The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.

Which segment is dominating the asthma drugs market by medication?

The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.

Which segment is expected to dominate the asthma drugs market by route of administration?

On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Asthma Drugs Market

  1. AstraZeneca
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  3. GlaxoSmithKline plc
  4. Boehringer Ingelheim International GmbH
  5. Merck & Co., Inc.
  6. Koninklijke Philips NV
  7. Sanofi
  8. Pfizer Inc.
  9. Novartis AG
  10. Abbott

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports